Sleep Quality & Psoriatic Arthritis
For people living with psoriatic arthritis (PsA), the comfort of a good night's sleep may feel out of reach for many.
Read more →What's hot
View all perspectives
What's Hot
Ultrasound in PsA
Dr. Arthur Kavanaugh discusses abstract 2206 presented at ACR22 in Philadelphia. Abstract 2206: Understanding Inter-rater Variability in Scoring of Entheseal Lesions: Results from the Diagnostic Ultrasound Enthesitis Tool (DUET) Study
Watch video →
Tapering TNFi in nonradiographic AxSpA
Dr. Peter Nash at ACR22 Convergence in Philadelphia, PA.
Watch video →
Sunday (Day 2): ACR 22 Daily Recap
ACR 2022 Daily Recap for Sunday, November 13th. Panelists: Drs. Robert Chao, Antoni Chan, Bella Mehta, Janet Pope, Yuz Yusof, Cassy Sims, Akhil Sood, Sheila Reyes and Jack Cush.
Watch video →
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler discusses the following abstracts presented at ACR22 Convergence. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
Watch video →
Deucravacitinib in PsA
Dr. Arthur Kavanaugh discusses abstract 1598 at ACR22 Convergence in Philadelphia. Abstract 1598: Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial
Watch video →
Sarilumab in Polymyalgia Rheumatica: Results from SAPHYR Trial
Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 1676: Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)
Watch video →
PET CT Imaging to Define Risk of Progression from PSO to PsA
Dr. Peter Nash discusses Abstract 1018 at ACR22 Convergence.
Watch video →
ACR22 Daily Recap: Saturday Recap
Panelists: Drs. Jack Cush, Michael Putman, Eric Dein, Patricia Harkins and Rachel Tate.
Watch video →
Richard Conway RichardPAConway
3 years 1 month ago
Botson et al. 52 week results MIRROR trial. MTX added to pegloticase. 71% vs 39% SU <6mg/dl. Infusion reaction 13% vs 32% if ab+ 0% vs 30% ab- @RheumNow #ACR22 Abstr#0001 #ACRbest https://t.co/1c3Va9NxNX https://t.co/dPGDyWue4G
Richard Conway RichardPAConway
3 years 1 month ago
England et al. Influence of FVC on choice of b/tsDMARD in RA-ILD. FVC predicts hospitalisation and mortality. However, it did not appear to influence choice of b/tsDMARD. Overall 67% of RA-ILD patients initiated TNFi, weird! @rheumnow #ACR22 Abstr#245 https://t.co/swuNHv96WD https://t.co/vy5FUPnNjo
Dr. Rachel Tate uptoTate
3 years 1 month ago
Interesting observation: Late-onset PsA assoc'd w/ male sex, greater structural damage, higher frequency of arthritis, and greater loss of functionality (BASFI). Interestingly, shorter time of symptom duration to dx. Abs 0377 #ACR22 @RheumNow https://t.co/m15c37FltD https://t.co/3LRy4Ltde6
Janet Pope Janetbirdope
3 years 1 month ago
#ClinicalPearl #Methotrexate is recommended for Rx in all EXCEPT…#ACR22 @RheumNow
Janet Pope Janetbirdope
3 years 1 month ago
Difficult to treat #rheumatoidarthritis - phenotypes need to be defined and order of Rx may be v Impt. Well, it is really difficult @RheumNow #ACR22 session 12S127 https://t.co/x3bkUP590A
David Liew drdavidliew
3 years 1 month ago
So does PsA affect your capacity to work?
DISCOVER-2 analysis:
It’s presenteeism, not absenteeism which is the issue
PsA pts drag themselves into work, but treating them helps them actually do their job. We need to fund more rheumatologists!
ABST0509 @RADoctor #ACR22 @RheumNow https://t.co/Jnac6mV9O5
TheDaoIndex KDAO2011
3 years 1 month ago
#RheumPearl: Dr. J Stone shares useful #ophthalmology terms that #rheums should know. Note that IOI may not be idiopathic (do the workup- it might be #sarcoid myositis). Does @DGlaucomflecken have anything to add? #ACR22 @rheumnow https://t.co/bxWm7MlePj
Richard Conway RichardPAConway
3 years 1 month ago
Michailidou et al. Predictive models VTE in GCA. Predictors Age, inpatient status at the time of diagnosis of GCA, numberof admissions before diagnosis of GCA, Charlson comorbidity index @rheumnow #ACR22 Abstr#0458 https://t.co/TVZ53sERrS https://t.co/JzUuEZThY0
Richard Conway RichardPAConway
3 years 1 month ago
BIOBADASAR study of cancer risk in RA patients with prev cancer treated with b/tsDMARD. No increased risk, but yet again abatacept numbers are making me slightly nervous! @rheumnow #ACR22 Abstr#0267 https://t.co/H8gYm9STT3 https://t.co/sEIS6Ljwao
Akhil Sood MD AkhilSoodMD
3 years 1 month ago
Rheumatology Secrets & Pearl Lecture
with Dr. John Stone:
- Patient presenting with fever, headache, neck pain, and CPPD of multiple joints.
- Consider Crowned Dens Syndrome. CT Neck showing calcification around Odontoid Process
@RheumNow #ACR22 https://t.co/Md1bqzPyr5
Richard Conway RichardPAConway
3 years 1 month ago
Henningson et al. IV methylpred in GCA. No better visual acuity, higher cumulative GC at 3 months, higher diabetes. Interesting! I find it so hard not to give, in case the contralateral eye gets it, but no evidence for this @rheumnow #ACR22 Abstr#0459 https://t.co/yMcw2HGQUx https://t.co/tNKUgYNTdG
Dr. Rachel Tate uptoTate
3 years 1 month ago
Morning stiffness has the highest correlate to disease activity in pregnant AS patients, as demonstrated in Abs 0374. I will indeed be focusing on this much more for my patients. #ACR22 #ACRbest @RheumNow https://t.co/9bmlQtGsLH https://t.co/qrxebQ6Ow1
Dr. John Cush RheumNow
3 years 1 month ago
RheumNow’s expanded coverage of the #ACR22 Annual meeting is sponsored in part by Novartis. All content chosen by RheumNow & its Faculty
Richard Conway RichardPAConway
3 years 1 month ago
Kunishita et al Abatacept in those with RA and prev cancer (or not). Equally effective. No significant difference in 5-year malignancy but those curves look like they are diverging to me! @rheumnow #ACR22 Abstr#0255 https://t.co/1E2SXMGbqD https://t.co/gTvOOnuzo0
Janet Pope Janetbirdope
3 years 1 month ago
What do you do if a person with #rheumatoidarthritis was great on 1st JAKi. It was 1st line advanced Rx @RheumNow #ACR22
Poster Hall